Skip to content

A Clinical trial to study and compare the effects of platelet rich plasma and genicular nerve block and platelet rich plasma in patients with osteoarthritis knee.

efficacy of single intraarticular platelet rich plasma injection versus the combination of genicular nerve block and intraarticular platelet rich plasma injection in patients with knee osteoarthritis : a randomised controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046422
Enrollment
60
Registered
2022-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: autologous platelet-rich plasma: the intraarticular platelet-rich plasma will be injected with the patient in a seated position with the knee in 90 degrees of flexion using a 21G needle

Sponsors

All india institute of medical sciences Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: primary osteoarthritis knee diagnosed with ACR criteria with age more than 50 years and presence of crepitus on active motion and less than 30 minutes of morning stiffness with bony tenderness and bony overgrowth with no palpable warmth of synovium with KL grade 1 and 2 and nonresponders to standard of care for oa knee and radiological confirmed oa knee

Exclusion criteria

Exclusion criteria: secondary oa knee and any prior knee surgery and any connective tissue disorder and serious neurological or psychiatric disorder and patient on anticoagulants and any fracture and vascular disease of lower limbs and joint effusions and uncontrolled diabetes mellitus and blood platelet count less than or equal to one lakh fifty thousand per microlitres and hepatitis b c or hiv

Design outcomes

Primary

MeasureTime frame
WOMAC scoreTimepoint: at baseline then 4 weeks then 12 weeks

Secondary

MeasureTime frame
articular cartilage thicknessTimepoint: at baseline then at 12 weeks;efficacy of standard of care for osteoarthritis kneeTimepoint: at 12 weeks;serum CRP levelsTimepoint: at baseline then at 12 weeks

Countries

India

Contacts

Public ContactDr Mohit Kishore Srivastava

Associate professor and Head of Department, Department of PMR

rajky4u@yahoo.com8800264547

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026